Medtronic is modestly undervalued based on DCF analysis, but slow revenue growth limits upside potential. Read why I ...
Beta Bionics announced today that it launched the integration of the iLet bionic pancreas with the Abbott (NYSE:ABT) ...
The global injection pen market is poised for significant growth, with projections indicating a robust compound annual growth rate (CAGR) of 7.0% from 2022 to 2033. The market is expected to escalate ...
Roche is teaming up with two medical tech companies to develop an automated insulin delivery system, the first steps towards an ‘artificial pancreas.’ The Swiss pharma will work with existing ...
and loved ones who want to see iLet pump and CGM data regardless of whether they're using an iPhone or Android device. The free app can be downloaded from the Apple App store or Google Play. Medtronic ...
ABBOTT PARK, Ill. – Abbott will enter a global partnership with Medtronic to collaborate on an integrated continuous glucose monitoring (CGM) system based on Abbott's FreeStyle Libre technology and ...
continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland. Latest Health Care Equipment & Supplies and ...
A new consensus statement offers “considerations and good practice points” for the use of continuous glucose monitoring ...
One system consisted of a Stockert SIII roller pump (Sorin Group USA, Arvada, CO) with a Tygon S-95 tubing raceway (Saint-Gobain Performance Plastics, Portage, WI), a Medtronic 0800 or 1500 ...